GSE207499 sphingosine 1 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE207499_sphingosine_1_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE207499_sphingosine_1_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE207499_sphingosine_1_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE207499_sphingosine_1_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

Pvt1 oncogene

Gene

GOLGA2 pseudogene 7

Gene

general transcription factor IIi pseudogene 4

Gene

MT-CO2 pseudogene 12

Gene

urothelial cancer associated 1

Gene

H3 clustered histone 6

Gene

PSMG3 antisense RNA 1

Gene

tripartite motif containing 31

Gene

transmembrane protein 198B (pseudogene)

Gene

hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA


  • Gene

    GOLGA2 pseudogene 7


  • Gene

    general transcription factor IIi pseudogene 4


  • Gene

    MT-CO2 pseudogene 12


  • Gene

    urothelial cancer associated 1


  • Gene

    H3 clustered histone 6


  • Gene

    PSMG3 antisense RNA 1


  • Gene

    tripartite motif containing 31


  • Gene

    transmembrane protein 198B (pseudogene)


  • Gene

    hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.